Company type | Public |
---|---|
Traded as | TSE: DLGM1 ISIN: IRO1DLGM0000 |
Industry | |
Founded | 1968; 57 years ago (1968) |
Headquarters | Tehran, Iran |
Area served | Worldwide |
Key people | Khosro Davari, chief executive officer Alireza Zohrevand, Chairman |
Products | Pharmaceutical drug Ampoule, Tablet (pharmacy), Capsule (pharmacy) |
Net income | 44 Billion IRR (2009) |
Total assets | 437 Billion IRR (2009) |
Website | www.loghmanpharma.com |
Loghman Pharmaceutical & Hygienic Co. (Persian: شرکت دارویی و بهداشتی لقمان, Shirkat-e Darvii-ye vâ Behedashiti-ye Laqman) is an Iranian pharmaceuticals company. The company engages in the discovery, development, manufacture, and marketing of drugs in Iran.
History
Loghmans was established in 1968 as I.D.I. Pharmaceuticals. In 1979, the company changed its name to Loghman and expanded its operations.
The company has been listed on the Tehran Stock Exchange since 1997.
products
- Acetaminophen+Codeine
- Amoxicillin
- Azithromycin
- Buspirone
- Carbamazepine
- Cefalexin
- Cefazolin
- Cefepime
- Cefixime
- Ceftazidime
- Ceftriaxone
- Cefuroxime
- Cefalexin
- Diazepam
- Erythromycin
- Fluconazole
- Sodium Fluoride
- Ibuprofen
- Indomethacin
- Lorazepam
- Losartan Potassium
- Meropenem
- Methimazole
- Nortriptyline
- Phenytoin
- Sodium Fluoride
- Sorbitol
- Valsartan
Development plan
See also
References
- "Stocks". Archived from the original on October 5, 2012.
- "شرکت دارویی بهداشتی لقمان". Archived from the original on 2013-07-08. Retrieved 2013-06-08.
- "Dlgm1 37,480".
This Iran-related article is a stub. You can help Misplaced Pages by expanding it. |